Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Strom

Showing results (21-30 of 382) with videos related to

Pageof 39
Sort By:
Kidney International|April 1, 1989
Toward more selective therapies to block undesired immune responsesT B Strom, V E Kelley
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 20, 2015
Firmly tilting the balance of clinical transplant immunity toward toleranceT B Thornley, T B Strom
The New England Journal of Medicine|January 27, 1977
Hepatitis B, transfusions and renal transplantationT B Strom, J P Merrill
Clinical Immunology and Immunopathology|October 1, 1986
Spleen cell factor inhibits lymphoproliferation, abnormal Ia expression and overt autoimmunity in MRL-lpr miceV E Kelley, T B Strom
Experimental Cell Research|October 1, 1979
Absence of a role for the cellular exoskeleton in the emergence of the T lymphocyte insulin receptorJ H Helderman, T B Strom
Nephron|August 18, 1999
Posttransplant recurrent FSGS: molecular insights and future directionsA D Schachter, T B Strom
The Journal of Biological Chemistry|August 10, 1979
Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytesJ H Helderman, T B Strom
Hospital Practice (Office Ed.)|December 1, 1982
Transplantation: immunogenetic and clinical aspects--Part IC B Carpenter, T B Strom
Transplantation Proceedings|February 1, 1987
Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement componentsV E Kelley, T B Strom
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1981
Clinical and experimental aspects of renal allograft rejectionT B Strom, M R Garovoy
Pageof 39

Showing results (21-30 of 382) with videos related to

Sort By:
Pageof 39
Kidney International|April 1, 1989
Toward more selective therapies to block undesired immune responsesT B Strom, V E Kelley
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 20, 2015
Firmly tilting the balance of clinical transplant immunity toward toleranceT B Thornley, T B Strom
The New England Journal of Medicine|January 27, 1977
Hepatitis B, transfusions and renal transplantationT B Strom, J P Merrill
Clinical Immunology and Immunopathology|October 1, 1986
Spleen cell factor inhibits lymphoproliferation, abnormal Ia expression and overt autoimmunity in MRL-lpr miceV E Kelley, T B Strom
Experimental Cell Research|October 1, 1979
Absence of a role for the cellular exoskeleton in the emergence of the T lymphocyte insulin receptorJ H Helderman, T B Strom
Nephron|August 18, 1999
Posttransplant recurrent FSGS: molecular insights and future directionsA D Schachter, T B Strom
The Journal of Biological Chemistry|August 10, 1979
Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytesJ H Helderman, T B Strom
Hospital Practice (Office Ed.)|December 1, 1982
Transplantation: immunogenetic and clinical aspects--Part IC B Carpenter, T B Strom
Transplantation Proceedings|February 1, 1987
Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement componentsV E Kelley, T B Strom
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1981
Clinical and experimental aspects of renal allograft rejectionT B Strom, M R Garovoy
Pageof 39